Distinct patterns of sirtuin expression during progression of Alzheimer's disease

NeuroMolecular Medicine

Volumn 16, Issue 2, 2014, Pages 405-414

  Lutz, Mirjam I ^a   Milenkovic, Ivan ^a   Regelsberger, Günther ^a   Kovacs, Gabor G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aging; Alzheimer's disease; Hippocampus; SIRT1; SIRT3; SIRT5; Sirtuin

Indexed keywords

AMYLOID BETA PROTEIN; SIRTUIN; SIRTUIN 1; SIRTUIN 3; SIRTUIN 5; TAU PROTEIN; MAPT PROTEIN, HUMAN; NERVE PROTEIN; SIRT1 PROTEIN, HUMAN; SIRT3 PROTEIN, HUMAN; SIRT5 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROGLIA; MORPHOMETRICS; NERVE DEGENERATION; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER; ADULT; AGED; BIOSYNTHESIS; CELL FRACTIONATION; CHEMISTRY; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; SIRTUIN 1; SIRTUIN 3; SIRTUINS; SUBCELLULAR FRACTIONS; TAU PROTEINS; WHITE MATTER;

EID: 84901352729     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-014-8288-8     Document Type: Article

References (67)

1. Adori, C., Kovács, G. G., Low, P., et al. (2005). The ubiquitin-proteasome system in Creutzfeldt-Jakob and Alzheimer disease: Intracellular redistribution of components correlates with neuronal vulnerability. Neurobiol Dis., 19, 427-435.
2. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., Murtagh F.R. (1995). An English translation of Alzheimer's 1907 paper, Uber eine eigenartige Erkankung der Hirnrinde. Clin Anat (New York, NY) 8: 429-431.
3. Baur, J. A., Pearson, K. J., Price, N. L., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
4. Boily, G., Seifert, E. L., Bevilacqua, L., et al. (2008). SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One, 3, e1759.
5. Boyden, S. E., & Kunkel, L. M. (2010). High-density genomewide linkage analysis of exceptional human longevity identifies multiple novel loci. PLoS One, 5, e12432.
6. Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropatholog, 82, 239-259.
7. Brenmoehl, J., & Hoeflich, A. (2013). Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion. doi: 10.1016/j.mito.2013. 04.002.
8. Cai, D. (2013). Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metabol TEM, 24, 40-47.
9. Cantó, C., & Auwerx, J. (2009). Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metabol TEM, 20, 325-331.
10. Chen, J., Zhou, Y., Mueller-Steiner, S., et al. (2005). SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem, 280, 40364-40374.
11. Costantini, S., Sharma, A., Raucci, R., et al. (2013). Genealogy of an ancient protein family: The Sirtuins, a family of disordered members. BMC Evol Biol, 13, 60.
12. Dai, H., Kustigian, L., Carney, D., et al. (2010). SIRT1 activation by small molecules: Kinetic and biophysical evidence for direct interaction of enzyme and activator. J Biol Chem, 285, 32695-32703.
13. De Luca, M., Rose, G., Bonafè, M., et al. (2001). Sex-specific longevity associations defined by Tyrosine Hydroxylase-Insulin-Insulin Growth Factor 2 haplotypes on the 11p15.5 chromosomal region. Exp Gerontol, 36, 1663-1671.
14. Dimauro, I., Pearson, T., Caporossi, D., & Jackson, M. J. (2012). A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res Notes, 2012(5), 513.
15. Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010). SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell, 142, 320-332.
16. Du, J., Zhou, Y., Su, X., et al. (2011). Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science, 334, 806-809.
17. Duyckaerts, C., Delatour, B., & Potier, M. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol, 118, 5-36.
18. Gan, L., & Mucke, L. (2008). Paths of convergence: Sirtuins in aging and neurodegeneration. Neuron, 58, 10-14.
19. Geng, Y.-Q., Li, T-. T., Liu, X.-Y., et al. (2011). SIRT1 and SIRT5 activity expression and behavioral responses to calorie restriction. J Cell Biochem, 112, 3755-3761.
20. Glorioso, C., Oh, S., Douillard, G. G., & Sibille, E. (2011). Brain molecular aging, promotion of neurological disease and modulation by sirtuin 5 longevity gene polymorphism. Neurobiol Dis, 41, 279-290.
21. Goedert, M., & Spillantini, M. G. (2006). A century of Alzheimer's disease. Science, 314, 777-781.
22. Hall, J. A., Dominy, J. E., Lee, Y., & Puigserver, P. (2013). The sirtuin family's role in aging and age-associated pathologies. J Clin Invest, 123, 973-979.
23. Han, C., & Someya, S. (2013). Maintaining good hearing: Calorie restriction, Sirt3, and glutathione. Exp Gerontol. doi: 10.1016/j.exger.2013.02. 014.
24. Herskovits, A. Z., & Guarente, L. (2013). Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Res, 23, 746-758.
25. Hisahara, S., Chiba, S., Matsumoto, H., et al. (2008). Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci USA, 105, 15599-15604.
26. Höftberger, R., Fink, S., Aboul-Enein, F., et al. (2010). Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis. Glia, 58, 1847-1857.
27. Houtkooper, R. H., Pirinen, E., & Auwerx, J. (2012). Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol, 13, 225-238.
28. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196.
29. Imai, S., & Guarente, L. (2010). Ten years of NAD-dependent SIR2 family deacetylases: Implications for metabolic diseases. Trends Pharmacol Sci, 31, 212-220.
30. Jin, Q., Yan, T., Ge, X., et al. (2007). Cytoplasm-localized SIRT1 enhances apoptosis. J Cell Physiol, 213, 88-97.
31. Julien, C., Tremblay, C., Emond, V., et al. (2009). Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol, 68, 48-58.
32. Kim, D., Nguyen, M. D., Dobbin, M. M., et al. (2007). SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J, 26, 3169-3179.
33. Körner, S., Böselt, S., Thau, N., et al. (2013). Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: Neuroprotective or neurotoxic properties of Sirtuins in ALS? Neurodegener Dis, 11, 141-152.
34. Koubova, J., & Guarente, L. (2003). How does calorie restriction work? Genes Dev, 17, 313-321.
35. Kumar, R., Chaterjee, P., Sharma, P. K., et al. (2013). Sirtuin1: A promising serum protein marker for early detection of Alzheimer's disease. PLoS One. doi: 10.1371/journal.pone.0061560.
36. Li, X., Zhang, S., Blander, G., et al. (2007). SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell, 28, 91-106.
37. Luo, J., Nikolaev, A. Y., Imai, S., et al. (2001). Negative control of p53 by Sir2α promotes cell survival under stress. Cell, 107, 137-148.
38. Lynch, C. J., Shah, Z. H., Allison, S. J., et al. (2010). SIRT1 undergoes alternative splicing in a novel auto-regulatory loop with p53. PLoS One, 5, e13502.
39. Mahlknecht, U., Ho, A. D., Letzel, S., & Voelter-Mahlknecht, S. (2006). Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization. Cytogenet Genome Res, 112, 208-212.
40. Matsushita, N., Yonashiro, R., Ogata, Y., et al. (2011). Distinct regulation of mitochondrial localization and stability of two human Sirt5 isoforms. Genes cells, 16, 190-202.
41. Michishita, E., Park, J. Y., Burneskis, J. M., et al. (2005). Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell, 16, 4623-4635.
42. Min, S.-W., Cho, S.-H., Zhou, Y., et al. (2010). Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron, 67, 953-966.
43. Mirra, S. S., Heyman, A., McKeel, D., et al. (1991). The consortium to establish a registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41, 479-486.
44. Misiak, B., Leszek, J., & Kiejna, A. (2012). Metabolic syndrome, mild cognitive impairment and Alzheimer's disease-the emerging role of systemic low-grade inflammation and adiposity. Brain Res Bull, 89, 144-149.
45. Montine, T. J., Phelps, C. H., Beach, T. G., et al. (2012). National institute on Aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol, 123, 1-11.
46. Mrak, R., & Griffin, W. (2005). Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging, 26, 349-354.
47. Onyango, P., Celic, I., McCaffery, J. M., et al. (2002). SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA, 99, 13653-13658.
48. Oppenheimer, H., Gabay, O., Meir, H., et al. (2012). 75-kd sirtuin 1 blocks tumor necrosis factor α-mediated apoptosis in human osteoarthritic chondrocytes. Arthritis Rheum, 64, 718-728.
49. Panza, F., Frisardi, V., Capurso, C., et al. (2010). Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. J Alzheimer's Dis, 21, 691-724.
50. Park, J. (2013). SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell, 50, 919-930.
51. Peng, C., Lu, Z., Xie, Z., et al. (2011). The first identification of lysine malonylation substrates and its regulatory enzyme. Mol Cell Proteom, 10(M111), 012658.
52. Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010). Microglia in neurodegenerative disease. Nat Rev Neurol, 6, 193-201.
53. Polito, L., Kehoe, P. G., Forloni, G., & Albani, D. (2010). The molecular genetics of sirtuins: Association with human longevity and age-related diseases. Int J Mol Epidemiol Genetics, 1, 214-225.
54. Qin, W., Yang, T., Ho, L., et al. (2006). Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem, 281, 21745-21754.
55. Ramadori, G., Lee, C. E., Bookout, A. L., et al. (2008). Brain SIRT1: Anatomical distribution and regulation by energy availability. J Neurosci, 28, 9989-9996.
56. Rice, C. M., Sun, M., Kemp, K., et al. (2012). Mitochondrial sirtuins-a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci, 35, 1887-1893.
57. Rose, G., Dato, S., Altomare, K., et al. (2003). Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol, 38, 1065-1070.
58. Sakamoto, J., Miura, T., Shimamoto, K., & Horio, Y. (2004). Predominant expression of Sir2α, an NAD-dependent histone deacetylase, in the embryonic mouse heart and brain. FEBS Lett, 556, 281-286.
59. Schwer, B., North, B. J., Frye, R. A., et al. (2002). The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol, 158, 647-657.
60. Sugino, T., Maruyama, M., Tanno, M., et al. (2010). Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells. FEBS Lett, 584, 2821-2826.
61. Tanno, M., Sakamoto, J., Miura, T., et al. (2007). Nucleocytoplasmic shuttling of the NAD + -dependent histone deacetylase SIRT1. J Biol Chem, 282, 6823-6832.
62. Thal, D. R., Rub, U., Orantes, M., & Braak, H. (2002). Phases of A-deposition in the human brain and its relevance for the development of AD. Neurology, 58, 1791-1800.
63. uniprot.com. (2013). NAD-dependent protein deacetylase sirtuin-1 - Homo sapiens (Human). http://www.uniprot.org/uniprot/Q96EB6#PRO-0000415289.
64. Vasiljevic, M., Heisler, F. F., Hausrat, T. J., et al. (2012). Spatio-temporal expression analysis of the calcium-binding protein calumenin in the rodent brain. Neuroscience, 202, 29-41.
65. Vaziri, H., Dessain, S. K., Eaton, E. N., et al. (2001). hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase. Cell, 107, 149-159.
66. Wood, J. G., Rogina, B., Lavu, S., et al. (2004). Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430, 686-689.
67. Zhang, Z., Tan, M., Xie, Z., et al. (2011). Identification of lysine succinylation as a new post-translational modification. Nat Chem Biol, 7, 58-63.